3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Thrombocythemia, Essential
1
Recurrence
1
Primary Myelofibrosis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Interventions
Cyclophosphamide
627
pembrolizumab
506
Paclitaxel
455
Gemcitabine
439
Carboplatin
438
Cisplatin
421
Radiotherapy
382
fludarabine
368
Nivolumab
340
Docetaxel
278
Bevacizumab
276
Irinotecan
258
Magnetic Resonance Spectroscopy
246
Fluorouracil
229
Dexamethasone
225
Specimen Handling
224
Capecitabine
218
Rituximab
206
Oxaliplatin
201
Cytarabine
201
Biopsy
198
Temozolomide
197
Ipilimumab
197
fludarabine phosphate
195
Etoposide
181
Lenalidomide
176
Doxorubicin
175
Leucovorin
174
Injections
171
Cetuximab
171
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Interventional
×
INCB057643
×
Clear all
NCT04279847
2026-04-01
LIMBER
Incyte Corporation
Phase 1
Active not recruiting
140 enrolled